Factors | ADAM10 expression | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|
Low (mean ± SE) | High (mean ± SE) | p-value | OR (95%CI) | p-value | OR (95%CI) | p-value | |
Age at diagnosis (years) | |||||||
 < 55 | 34 (120.4 ± 54.60) | 15 (252.0 ± 34.58) | 0.008** | 0.35 (0.12–1.00) | 0.050 | 0.96 (0.19–4.77) | 0.963 |
 ≥ 55 | 39 (91.2 ± 62.02) | 6 (297.5 ± 6.12) |  |  |  |  |  |
Menopause | |||||||
Yes | 53 (98.9 ± 62.35) | 10 (277.5 ± 27.61) | 0.024* | 0.34 (0.13–0.93) | 0.036* | 0.45 (0.05–0.53) | 0.292 |
No | 20 (120.5 ± 51.9) | 11 (253.6 ± 39.94) |  |  |  |  |  |
BMI (kg/m2) | |||||||
 > 23 | 51 (106.7 ± 56.50) | 6 (245.0 ± 37.55) | 0.023* | 5.80 (1.99–16.91) | 0.001** | 0.17 (0.10–2.00) | 0.002** |
 ≤ 23 | 22 (100.5 ± 68.97) | 15 (273.0 ± 33.16) |  |  |  |  |  |
Histological grade | |||||||
I | 4 (95.0 ± 72.23) | 2 (262.5 ± 53.03) | 0.172 | 0.55 (0.18–1.65) | 0.286 |  |  |
II | 56 (98.4 ± 59.23) | 17 (270.0 ± 34.37) |  |  |  |  |  |
III | 13 (135.4 ± 55.28) | 2 (225.0 ± 21.21) |  |  |  |  |  |
Tumor size | |||||||
T1 | 4 (78.8 ± 55.43) | 2 (262.5 ± 53.03) | 0.683 | 0.89 (0.29–2.76) | 0.846 |  |  |
T2 | 60 (104.8 ± 62.52) | 16 (266.3 ± 37.35) |  |  |  |  |  |
T3 | 9 (116.1 ± 45.26) | 3 (260.0 ± 31.22) |  |  |  |  |  |
Distant metastasis (before NACT) | |||||||
Yes | 4 (107.5 ± 70.77) | 3 (300) | 0.287 | 0.56 (0.06–4.92) | 0.599 |  |  |
No | 53 (109.7 ± 63.91) | 16 (282.2 ± 21.37) |  |  |  |  |  |
Regional lymphatic metastasis (after NACT) | |||||||
Yes | 38 (103.3 ± 62.63) | 9 (283.3 ± 21.79) | 0.066 | 1.42 (0.52–3.83) | 0.492 |  |  |
No | 19 (122.1 ± 65.77) | 10 (286.5 ± 20.55) |  |  |  |  |  |
Response to NACT | |||||||
Good | 58 (99.5 ± 59.41) | 11 (285 ± 27.66) | 0.023* | 0.28 (0.10–0.79) | 0.016* | 0.29 (0.44–16.22) | 0.042* |
Poor | 15 (125.3 ± 60.34) | 10 (243.0 ± 31.46) |  |  |  |  |  |